An Easy-to-Use, Affordable Cell Sorter for Core Facilities and Individual Research Labs
Hercules, CA — June 25, 2013 — Bio-Rad Laboratories, Inc. today announced the launch of its S3 cell sorter, an automated benchtop cell sorter that even novices find easy to use.
Historically, cell sorting systems have primarily been used at core labs due to the high cost of equipment and the sophisticated methods needed by immunologists, the systems’ main users. As more researchers began to use the instruments for sorting experiments requiring less than four fluorescent parameters, wait-list times ballooned.
“Cell sorting and flow cytometry are not just tools for immunologists anymore,” said Steve Kulisch, manager of the cell biology business unit at Bio-Rad. “The S3 cell sorter meets the needs of most researchers at a very affordable price and can ease bottlenecks at core facilities by serving as a supplementary instrument for basic cell sorting work.”
The S3 cell sorter is equipped with one or two lasers (488 nm and either 561 or 640 nm) enabling up to four-color detection along with forward- and side-scatter detectors. The S3 system is ideal for sorting cells expressing fluorescent proteins and cells labeled with fluorescent markers, and for isolating individual cells for single-cell PCR or digital PCR studies. The S3 cell sorter allows researchers to sort cells at high speeds while maintaining high sensitivity and purity.
Key benefits include:
- Simplified experimental setup — automatic instrument setup and calibration in less than 30 minutes with minimal training
- Automatic cleaning — reduced carryover thanks to a dual-position loading stage that ensures the sample line is cleaned between sorting runs
- Small benchtop footprint — internalized fluidics and temperature control system for a compact size (2.3 × 2.1 × 2.1 ft)
For more information about the S3 cell sorter, please visit www.bio-rad.com/cellsorter.
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) has been at the center of scientific discovery for more than 60 years, manufacturing and distributing a broad range of products for the life science research and clinical diagnostic markets. The company is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 100,000 research and industry customers worldwide through its global network of operations. The company employs over 7,300 people globally and had revenues exceeding $2 billion in 2012. For more information, visit www.bio-rad.com.
This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally can be identified by the use of forward-looking terminology such as, “believe,” “expect,” “may,” “will,” “intend,” “estimate,” “continue,” or similar expressions or the negative of those terms or expressions. Such statements involve risks and uncertainties, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. For further information regarding the Company's risks and uncertainties, please refer to the “Risk Factors” in the Company’s public reports filed with the Securities and Exchange Commission, including the Company’s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company cautions you not to place undue reliance on forward-looking statements, which reflect an analysis only and speak only as of the date hereof. Bio-Rad Laboratories, Inc., disclaims any obligation to update these forward-looking statements.
For more information contact:
Bio-Rad Laboratories, Inc.
312-997-2436 x 112